Canada approves Pfizer’s antiviral COVID-19 treatment for use

Jan. 17 (UPI) — Canada on Monday introduced it has approved Pfizer’s at-house coronavirus antiviral pill treatment to be used through adults with delicate to reasonable COVID-19 signs who are in peril of great illness that may lead to hospitalization or dying.

Well Being Canada stated the medication named Paxlovid is a combination of two antiviral medicine nirmatrelvir and ritonavir which can be intended for use as quickly as possible following a analysis of COVID-19 and inside five days of signs coming up.

Advertisement

Leave a comment

SMM Panel PDF Kitap indir